EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice

James Brett Case, Shilpa Sanapala, Carly Dillen, Victoria Rhodes, Christian Zmasek, Taras M Chicz, Charlotte E Switzer, Suzanne M Scheaffer, George Georgiev, Catherine Jacob-Dolan, Blake M Hauser, Déborah Carolina Carvalho Dos Anjos und 14 weitere

Cell Host & Microbe · 2024-12 · 32 (12) · 2131-2147.e8

DOI: 10.1016/j.chom.2024.10.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2024-12. Verfasst von James Brett Case und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19 Vaccines, Phylogeny, COVID-19. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The continued emergence of SARS-CoV-2 variants and the threat of future Sarbecovirus zoonoses have spurred the design of vaccines that can induce broad immunity against multiple coronaviruses. Here, we use computational methods to infer ancestral phylogenetic reconstructions of receptor binding domain (RBD) sequences across multiple Sarbecovirus clades and incorporate them into a multivalent adenoviral-vectored vaccine. Mice immunized with this pan-Sarbecovirus vaccine are protected in the upper and lower respiratory tracts against infection by historical and contemporary SARS-CoV-2 variants, SARS-CoV, and pre-emergent SHC014 and Pangolin/GD coronavirus strains. Using genetic and immunological approaches, we demonstrate that vaccine-induced protection unexpectedly is conferred principally by CD4+ and CD8+ T cell-mediated anamnestic responses. Importantly, prior mRNA vaccination or SARS-CoV-2 respiratory infection does not alter the efficacy of the mucosally delivered pan-Sarbecovirus vaccine. These data highlight the promise of a phylogenetic approach for antigen and vaccine design against existing and pre-emergent Sarbecoviruses with pandemic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19 VaccinesPhylogenyCOVID-19Spike Glycoprotein, CoronavirusAnimalsMiceHumansCD8-Positive T-LymphocytesFemaleAntibodies, ViralCD4-Positive T-LymphocytesVaccinationMice, Inbred C57BL

Stichwörter der Autor:innen

SarbecovirusT cellantibodycellular immunitycoronavirusimmunitymucosalphylogeneticvaccineviral vector

Substanzen

COVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antibodies, Viral

Autor:innen und Institutionen

  • Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Department of Microbiology and Immunology, Center for Pathogen Research, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Department of Informatics, J. Craig Venter Institute, La Jolla, CA 92037, USA.
  • Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston 02115, MA, USA; Department of Bioengineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • U.S. National Library of Medicine
  • National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases

Zitieren

APA

Case, J. B., Sanapala, S., Dillen, C., Rhodes, V., Zmasek, C., Chicz, T. M., Switzer, C. E., Scheaffer, S. M., Georgiev, G., Jacob-Dolan, C., Hauser, B. M., Dos Anjos, D. C. C., Adams, L. J., Soudani, N., Liang, C. Y., Ying, B., McNamara, R. P., Scheuermann, R. H., Boon, A. C. M., …, & Diamond, M. S. (2024). A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice. Cell Host & Microbe, 32(12), 2131-2147.e8. https://doi.org/10.1016/j.chom.2024.10.016

Vancouver

Case JB, Sanapala S, Dillen C, Rhodes V, Zmasek C, Chicz TM, et al. A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice. Cell Host & Microbe. 2024;32(12):2131-2147.e8. doi:10.1016/j.chom.2024.10.016

BibTeX
@article{Case2024,
  author = {Case, James Brett and Sanapala, Shilpa and Dillen, Carly and Rhodes, Victoria and Zmasek, Christian and Chicz, Taras M and Switzer, Charlotte E and Scheaffer, Suzanne M and Georgiev, George and Jacob-Dolan, Catherine and Hauser, Blake M and Dos Anjos, Déborah Carolina Carvalho and Adams, Lucas J and Soudani, Nadia and Liang, Chieh-Yu and Ying, Baoling and McNamara, Ryan P and Scheuermann, Richard H and Boon, Adrianus C M and Fremont, Daved H and Whelan, Sean P J and Schmidt, Aaron G and Sette, Alessandro and Grifoni, Alba and Frieman, Matthew B and Diamond, Michael S},
  title = {A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice},
  journal = {Cell Host & Microbe},
  year = {2024},
  volume = {32},
  number = {12},
  pages = {2131--2147.e8},
  doi = {10.1016/j.chom.2024.10.016}
}
Kostenlos starten →